Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV

NCT02116257 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02116257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02116257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2013
Completion date
March 31, 2015
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ponv, propacetamol